MAM
KRON

Marquette Asset Management’s Kronos Bio KRON Stock Holding History

Marquette Asset Management’s Portfolio KRON Stock Details KRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-80,369
Closed -$76.4K – 178
2024
Q4 		$76.4K Hold
80,369
– – 0.01% 141
2024
Q3 		$80.4K Hold
80,369
– – 0.01% 147
2024
Q2 		$99.7K Hold
80,369
– – 0.02% 108
2024
Q1 		$104K Buy
80,369
+13,269
+20% +$15.1K 0.02% 113
2023
Q4 		$83.9K Sell
67,100
-941
-1% -$1.04K 0.02% 123
2023
Q3 		$88.5K Hold
68,041
– – 0.02% 110
2023
Q2 		$117K Buy
68,041
+19,484
+40% +$30.9K 0.03% 107
2023
Q1 		$70.9K Hold
48,557
– – 0.02% 130
2022
Q4 		$78.7K Buy
+48,557
New +$112K 0.02% 127

Other funds holding KRON

VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCIG
Partners Capital Investment Group Boston, Massachusetts $2.83B AUM 20.31% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Marquette Asset Management's KRON Position: Q1 2025 in Review

Marquette Asset Management sold out of Kronos Bio (KRON) in Q1 2025, closing a stake of 80,369 shares — an estimated $76.4K sold.

Marquette Asset Management first reported a position in KRON in Q4 2022 and held it in 9 quarters. The position peaked at $117K in Q2 2023. 47 funds tracked by Wall St. Rank hold KRON as of Q1 2025.

  • Marquette Asset Management reported no remaining Kronos Bio position as of Q1 2025 after selling out during the quarter.
  • Marquette Asset Management sold 80,369 Kronos Bio shares in Q1 2025, an estimated $76.4K.
  • Marquette Asset Management first reported a position in Kronos Bio in Q4 2022 and held it in 9 quarters.
  • Marquette Asset Management's Kronos Bio position peaked at $117K in Q2 2023.
  • 47 funds tracked by Wall St. Rank held Kronos Bio as of Q1 2025.

Based on Marquette Asset Management's 13F filing for Q1 2025, filed 9 Apr 2025.